Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Pharmaceutical Logistics Market size was valued at USD 77.97 billion in 2019 and is poised to grow from USD 85.24 billion in 2023 to USD 170.17 billion by 2031, growing at a CAGR of 9.2% in the forecast period (2024-2031).

Pharma companies constantly undertake strategic initiatives, such as mergers and acquisitions, to maintain their market position. FedEx, for example, acquired Manton Air-Sea Pty Ltd., a logistics service provider, in October 2018. FedEx's geographical footprint in the Asia Pacific region was strengthened as a result of the acquisition. 'Agility Logistics', 'BDP International', 'CEVA Logistics', 'DHL Forwarding', 'FedEx Corporation', 'DB Schenker', 'Kuehne + Nagel', 'Penske Logistics', 'Cardinal Health', 'Marken', 'UPS Healthcare', 'Movianto', 'Panalpina World Transport', 'Rhenus Logistics', 'World Courier', 'XPO Logistics', 'Hellmann Worldwide Logistics', 'TNT Express', 'Expeditors International', 'Nippon Express'

Need to maintain cold chain integrity for pharmaceutical products while lowering distribution costs by creating a single source distribution channel is driving up demand for pharmaceutical logistics.

In pharmaceutical logistics, products are GPS tracked as well as remotely monitored temperature in accordance with GDP guidelines, ensuring safe transportation and delivery of the products. Additional precautions are taken to ensure the safe delivery of narcotics and pharmaceutical products. Different delivery patterns are used for different types of pharmaceuticals. Stringent reimbursement, regulations, direct sell models, pricing applied by government agencies, third-party logistics, product diversity, shipment of R&D products for clinical studies, difficulty forecasting a product's lifecycle, and counterfeit products are all issues in pharmaceutical supply chains.

Europe had a market share of more than 36.0% in 2021 and is expected to grow at a significant rate from 2022 to 2030. The significant growth in pharmaceutical product trades across key European countries is responsible for the high market share. These countries primarily include Germany, the United Kingdom, France, the Nordic countries, and others. Furthermore, growing domestic production and demand for several categories of pharma products, such as OTC medicines, has aided the market in gaining a sizable market share.

Feedback From Our Clients

Global Pharmaceutical Logistics Market

Product ID: SQMIG20R2031

$5,300
BUY NOW GET FREE SAMPLE